Global Cough Hypersensitivity Syndrome Treatment Market Size By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Drug Type (Antitussive Agents, Inhaled Corticosteroids), By Geographic Scope And Forecast

Cough Hypersensitivity Syndrome Treatment Market Size And Forecast

Cough Hypersensitivity Syndrome Treatment Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2022 to 2030.

The increase in the number of cases of chronic respiratory disorders worldwide is a major factor driving the growth of the Cough Hypersensitivity Syndrome Treatment Market. Furthermore, the global population of cigarette smokers has grown. Cigarette smoking is a major cause of cough in many people, and as a result, this factor has contributed to the market’s growth. The Global Cough Hypersensitivity Syndrome Treatment Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Cough Hypersensitivity Syndrome Treatment Market Definition

In adults, chronic cough is defined as lasting eight weeks or longer. Coughs lasting less than three weeks are classified as acute, while coughs lasting three to eight weeks are classified as subacute. Acute and subacute coughs are frequently self-resolving and primarily post-infective. Coughs are classified based on their duration, character, quality, and timing. On the other hand, the duration of cough is the most useful classification for clinical diagnosis and management.

Coughing is a protective automatic arc reflex that consists of three partsan afferent sensory limb, a central processing center, and an efferent limb. The trigeminal, glossopharyngeal, and vagus nerves provide afferent pathways for cough receptors, with the vagus providing the vast majority of these receptors via its pharyngeal, superior laryngeal, and pulmonary branches.

From the pharynx to the terminal bronchioles, receptors are found throughout the airway, with the greatest concentration in the larynx, carina, and the bifurcation of larger bronchi. Three types of receptors are – Rapidly adapting receptors (RARs), Slowly adapting receptors (SARs), and C-fibres. Afferent impulses are sent to the cough center of the brain, which is located in the medulla of the brainstem and is linked to the central pathways.

Efferent impulses leave the medulla and travel through the vagus, phrenic, and spinal motor nerves C3-S2 to the cortex. The cough reflex is neuroplastic in the sense that it elicits a hypersensitive response over time as a result of the cough itself inducing chronic irritation, inflammation, and tissue remodeling. Both peripheral and central sensitization can account for patients’ exaggerated cough response, which contributes to the persistence of chronic cough.

Global Cough Hypersensitivity Syndrome Treatment Market Overview

The growth drivers for the market are the High prevalence of chronic lung infections and diseases such as cough hypersensitivity syndrome, a Surge in the number of smokers globally, and vulnerable indoor as well as outdoor allergens. According to the World Health Organization’s report on the Global Impact of Respiratory Disease, 2 million people worldwide are exposed to toxic smoke from any type of biomass fuel, which is typically burned inefficiently, and one billion people inhale polluted air and are exposed to tobacco smoke, which leads to various types of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, acute lower respiratory tract infections, lung cancer, and so on.

These medical conditions cause patients to develop CHS. Because of urbanization and changes in lifestyle, there is an increase in people with behavioral risks such as tobacco consumption and smoking, which contributes to the prevalence of chronic diseases that cause CHS. These are the major forces propelling the Cough Hypersensitivity Syndrome Treatment Market forward. Recent advancements in CHS treatment, such as good-tasting syrups and liquid medications, are increasingly being used to treat pediatric patients, who are more susceptible to CHS due to low immunity.

On the other hand, the proportion of the aging population is increasing as the mortality rate rises. Aging people are also more vulnerable to chronic diseases and are more likely to develop CHS. Many people are also allergic to some of the medications used to treat other diseases that can result in CHS. CHS is also caused by Gastroesophageal Reflux Disease (GERD). The developing world, with an increasing number of chronic patients, is a growing market for CHS treatments, which will catalyze the market’s growth. All of these factors have a multiplier effect on the Cough Hypersensitivity Syndrome Treatment Market.

However, the presence of undesirable side effects, particularly with antitussives, is impeding market growth by slowing adoption. The restraints for the market growth are Drug abuse and dependence on cough hypersensitivity syndrome drugs. Whereas the opportunities are a Surge in research and development activities in the treatment of cough hypersensitivity syndrome Technological advancement in the field of drug delivery systems, and increasing awareness amongst patients.

Global Cough Hypersensitivity Syndrome Treatment MarketSegmentation Analysis

The Global Cough Hypersensitivity Syndrome Treatment Market is Segmented on the basis of Distribution Channel, Drug Type, And Geography.

Cough Hypersensitivity Syndrome Treatment Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Based on Distribution Channel, the market is bifurcated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Cough hypersensitivity syndrome treatment drugs are widely distributed through retail pharmacies. This segment dominates the global Cough Hypersensitivity Syndrome Treatment Market, due to an increase in the number of retail pharmacies in close proximity to patients, as well as increased sales of over-the-counter cough medication through these retail pharmacies.

Cough Hypersensitivity Syndrome Treatment Market, By Drug Type

• Antitussive Agents
• Inhaled Corticosteroids
• Anticholinergics
• Antihistamines
• Others

Based on Drug Type, the market is bifurcated into Antitussive Agents, Inhaled Corticosteroids, Anticholinergics, Antihistamines, and Others. The increased use of antitussive agents for cough hypersensitivity treatment, as well as ongoing research on the development of effective antitussive therapies, are driving the growth of the antitussive agent’s drug class segment in the Global Cough Hypersensitivity Syndrome Treatment Market.

Cough Hypersensitivity Syndrome Treatment Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

On the basis of Geography, The Global Cough Hypersensitivity Syndrome Treatment Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Because of the presence of major market players, North America has the largest share. Several collaborative efforts by major companies to improve their R&D capabilities and ensure high medical standards are expected to drive demand in this region. Furthermore, the majority share can be attributed to the region’s high disease burden. The key factors driving the market studied in this region are rising cough cases and a growing pediatric population.

Key Players

The “Global Cough Hypersensitivity Syndrome Treatment Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Novartis AG, Merck & Co Inc., Johnson & Johnson Consumer Inc, Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments